Junevity
Junevity is a biotech rewinding complex metabolic disease. Based on 6 years of breakthrough research at UCSF, Junevity's REWIND platform identifies high-level regulators of metabolic disease with known pharmacological pathways. Junevity is advancing multiple therapeutic programs towards a new era of medicines.
junevity.comCompany Details
Founded
- 2023
Employees
- Between 5 - 20 employees
Raised
- $10,000,000
Public
- No
Acquired
- No
CEO
Janine Sengstack
Founders
- Janine Sengstack
Company Collections
These are collections Junevity is a part of. Click on the collection name to view similar companies.
Junevity's Industries
Total Amount Raised: $10,000,000
Junevity Funding Rounds
Seed
$10,000,000
Seed Investors
Godfrey CapitalGoldcrest Capital
Funding info provided by Diffbot.
Junevity Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Junevity.